ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Kidney (Renal) Fibrosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-26K11964
Home | Market Reports | Health| Health Conditions
Global Kidney Renal Fibrosis Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Kidney (Renal) Fibrosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-26K11964
Report
September 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Pfizer Inc
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life Sciences Inc
BioLine Rx Ltd
Genzyme Corporation

Kidney (Renal) Fibrosis - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Kidney (Renal) Fibrosis - Market

Kidney (Renal) Fibrosis - Market

Kidney fibrosis is characterized by excessive production and deposition of extracellular matrix (ECM) proteins mainly in the kidney interstitium and results in structural damage, impairment of renal function, and eventually end-stage renal disease (ESRD).
The global market for Kidney (Renal) Fibrosis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney (Renal) Fibrosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Kidney (Renal) Fibrosis by region & country, by Type, and by Application.
The Kidney (Renal) Fibrosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney (Renal) Fibrosis.
Market Segmentation

Scope of Kidney (Renal) Fibrosis - Market Report

Report Metric Details
Report Name Kidney (Renal) Fibrosis - Market
CAGR 5%
Segment by Type:
  • Angiotensin Converting enzyme (ACE) Inhibitors
  • Pirfenidone
  • Renin Inhibitors
  • Angiotensin II Receptor Blockers (ARBs)
  • Vasopeptidase Inhibitors
Segment by Application
  • Research Center
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Pfizer, Roche, InterMune, Galectin Therapeutics, La Jolla Pharmaceutical Company, ProMetic Life-Sciences Inc., BioLine Rx Ltd, Genzyme Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Kidney (Renal) Fibrosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Kidney (Renal) Fibrosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Kidney (Renal) Fibrosis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Kidney (Renal) Fibrosis - Market report?

Ans: The main players in the Kidney (Renal) Fibrosis - Market are Merck, Pfizer, Roche, InterMune, Galectin Therapeutics, La Jolla Pharmaceutical Company, ProMetic Life-Sciences Inc., BioLine Rx Ltd, Genzyme Corporation

What are the Application segmentation covered in the Kidney (Renal) Fibrosis - Market report?

Ans: The Applications covered in the Kidney (Renal) Fibrosis - Market report are Research Center, Hospital, Clinic

What are the Type segmentation covered in the Kidney (Renal) Fibrosis - Market report?

Ans: The Types covered in the Kidney (Renal) Fibrosis - Market report are Angiotensin Converting enzyme (ACE) Inhibitors, Pirfenidone, Renin Inhibitors, Angiotensin II Receptor Blockers (ARBs), Vasopeptidase Inhibitors

1 Market Overview
1.1 Kidney (Renal) Fibrosis Product Introduction
1.2 Global Kidney (Renal) Fibrosis Market Size Forecast
1.3 Kidney (Renal) Fibrosis Market Trends & Drivers
1.3.1 Kidney (Renal) Fibrosis Industry Trends
1.3.2 Kidney (Renal) Fibrosis Market Drivers & Opportunity
1.3.3 Kidney (Renal) Fibrosis Market Challenges
1.3.4 Kidney (Renal) Fibrosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Kidney (Renal) Fibrosis Players Revenue Ranking (2023)
2.2 Global Kidney (Renal) Fibrosis Revenue by Company (2019-2024)
2.3 Key Companies Kidney (Renal) Fibrosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Kidney (Renal) Fibrosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Kidney (Renal) Fibrosis
2.6 Kidney (Renal) Fibrosis Market Competitive Analysis
2.6.1 Kidney (Renal) Fibrosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Kidney (Renal) Fibrosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Angiotensin Converting enzyme (ACE) Inhibitors
3.1.2 Pirfenidone
3.1.3 Renin Inhibitors
3.1.4 Angiotensin II Receptor Blockers (ARBs)
3.1.5 Vasopeptidase Inhibitors
3.2 Global Kidney (Renal) Fibrosis Sales Value by Type
3.2.1 Global Kidney (Renal) Fibrosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Kidney (Renal) Fibrosis Sales Value, by Type (2019-2030)
3.2.3 Global Kidney (Renal) Fibrosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Center
4.1.2 Hospital
4.1.3 Clinic
4.2 Global Kidney (Renal) Fibrosis Sales Value by Application
4.2.1 Global Kidney (Renal) Fibrosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Kidney (Renal) Fibrosis Sales Value, by Application (2019-2030)
4.2.3 Global Kidney (Renal) Fibrosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Kidney (Renal) Fibrosis Sales Value by Region
5.1.1 Global Kidney (Renal) Fibrosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Kidney (Renal) Fibrosis Sales Value by Region (2019-2024)
5.1.3 Global Kidney (Renal) Fibrosis Sales Value by Region (2025-2030)
5.1.4 Global Kidney (Renal) Fibrosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Kidney (Renal) Fibrosis Sales Value, 2019-2030
5.2.2 North America Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Kidney (Renal) Fibrosis Sales Value, 2019-2030
5.3.2 Europe Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Kidney (Renal) Fibrosis Sales Value, 2019-2030
5.4.2 Asia Pacific Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Kidney (Renal) Fibrosis Sales Value, 2019-2030
5.5.2 South America Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Kidney (Renal) Fibrosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Kidney (Renal) Fibrosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Kidney (Renal) Fibrosis Sales Value
6.3 United States
6.3.1 United States Kidney (Renal) Fibrosis Sales Value, 2019-2030
6.3.2 United States Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Kidney (Renal) Fibrosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Kidney (Renal) Fibrosis Sales Value, 2019-2030
6.4.2 Europe Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Kidney (Renal) Fibrosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Kidney (Renal) Fibrosis Sales Value, 2019-2030
6.5.2 China Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Kidney (Renal) Fibrosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Kidney (Renal) Fibrosis Sales Value, 2019-2030
6.6.2 Japan Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Kidney (Renal) Fibrosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Kidney (Renal) Fibrosis Sales Value, 2019-2030
6.7.2 South Korea Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Kidney (Renal) Fibrosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Kidney (Renal) Fibrosis Sales Value, 2019-2030
6.8.2 Southeast Asia Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Kidney (Renal) Fibrosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Kidney (Renal) Fibrosis Sales Value, 2019-2030
6.9.2 India Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Kidney (Renal) Fibrosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Profile
7.1.2 Merck Main Business
7.1.3 Merck Kidney (Renal) Fibrosis Products, Services and Solutions
7.1.4 Merck Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.1.5 Merck Recent Developments
7.2 Pfizer
7.2.1 Pfizer Profile
7.2.2 Pfizer Main Business
7.2.3 Pfizer Kidney (Renal) Fibrosis Products, Services and Solutions
7.2.4 Pfizer Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.2.5 Pfizer Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Kidney (Renal) Fibrosis Products, Services and Solutions
7.3.4 Roche Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.3.5 InterMune Recent Developments
7.4 InterMune
7.4.1 InterMune Profile
7.4.2 InterMune Main Business
7.4.3 InterMune Kidney (Renal) Fibrosis Products, Services and Solutions
7.4.4 InterMune Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.4.5 InterMune Recent Developments
7.5 Galectin Therapeutics
7.5.1 Galectin Therapeutics Profile
7.5.2 Galectin Therapeutics Main Business
7.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Products, Services and Solutions
7.5.4 Galectin Therapeutics Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.5.5 Galectin Therapeutics Recent Developments
7.6 La Jolla Pharmaceutical Company
7.6.1 La Jolla Pharmaceutical Company Profile
7.6.2 La Jolla Pharmaceutical Company Main Business
7.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Products, Services and Solutions
7.6.4 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.6.5 La Jolla Pharmaceutical Company Recent Developments
7.7 ProMetic Life-Sciences Inc.
7.7.1 ProMetic Life-Sciences Inc. Profile
7.7.2 ProMetic Life-Sciences Inc. Main Business
7.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Products, Services and Solutions
7.7.4 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.7.5 ProMetic Life-Sciences Inc. Recent Developments
7.8 BioLine Rx Ltd
7.8.1 BioLine Rx Ltd Profile
7.8.2 BioLine Rx Ltd Main Business
7.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Products, Services and Solutions
7.8.4 BioLine Rx Ltd Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.8.5 BioLine Rx Ltd Recent Developments
7.9 Genzyme Corporation
7.9.1 Genzyme Corporation Profile
7.9.2 Genzyme Corporation Main Business
7.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Products, Services and Solutions
7.9.4 Genzyme Corporation Kidney (Renal) Fibrosis Revenue (US$ Million) & (2019-2024)
7.9.5 Genzyme Corporation Recent Developments
8 Industry Chain Analysis
8.1 Kidney (Renal) Fibrosis Industrial Chain
8.2 Kidney (Renal) Fibrosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Kidney (Renal) Fibrosis Sales Model
8.5.2 Sales Channel
8.5.3 Kidney (Renal) Fibrosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Merck
Pfizer Inc
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life Sciences Inc
BioLine Rx Ltd
Genzyme Corporation
List of Tables
    Table 1. Kidney (Renal) Fibrosis Market Trends
    Table 2. Kidney (Renal) Fibrosis Market Drivers & Opportunity
    Table 3. Kidney (Renal) Fibrosis Market Challenges
    Table 4. Kidney (Renal) Fibrosis Market Restraints
    Table 5. Global Kidney (Renal) Fibrosis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Kidney (Renal) Fibrosis Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Kidney (Renal) Fibrosis Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Kidney (Renal) Fibrosis Product Type
    Table 9. Key Companies Time to Begin Mass Production of Kidney (Renal) Fibrosis
    Table 10. Global Kidney (Renal) Fibrosis Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Kidney (Renal) Fibrosis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Kidney (Renal) Fibrosis Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Kidney (Renal) Fibrosis Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Kidney (Renal) Fibrosis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Kidney (Renal) Fibrosis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Kidney (Renal) Fibrosis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Kidney (Renal) Fibrosis Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Kidney (Renal) Fibrosis Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Kidney (Renal) Fibrosis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Kidney (Renal) Fibrosis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Kidney (Renal) Fibrosis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Kidney (Renal) Fibrosis Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Kidney (Renal) Fibrosis Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Kidney (Renal) Fibrosis Sales Value by Region (2019-2024) & (%)
    Table 27. Global Kidney (Renal) Fibrosis Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Kidney (Renal) Fibrosis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Kidney (Renal) Fibrosis Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Kidney (Renal) Fibrosis Sales Value, (2025-2030) & (US$ Million)
    Table 31. Merck Basic Information List
    Table 32. Merck Description and Business Overview
    Table 33. Merck Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of Merck (2019-2024)
    Table 35. Merck Recent Developments
    Table 36. Pfizer Basic Information List
    Table 37. Pfizer Description and Business Overview
    Table 38. Pfizer Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of Pfizer (2019-2024)
    Table 40. Pfizer Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. InterMune Basic Information List
    Table 47. InterMune Description and Business Overview
    Table 48. InterMune Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of InterMune (2019-2024)
    Table 50. InterMune Recent Developments
    Table 51. Galectin Therapeutics Basic Information List
    Table 52. Galectin Therapeutics Description and Business Overview
    Table 53. Galectin Therapeutics Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of Galectin Therapeutics (2019-2024)
    Table 55. Galectin Therapeutics Recent Developments
    Table 56. La Jolla Pharmaceutical Company Basic Information List
    Table 57. La Jolla Pharmaceutical Company Description and Business Overview
    Table 58. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of La Jolla Pharmaceutical Company (2019-2024)
    Table 60. La Jolla Pharmaceutical Company Recent Developments
    Table 61. ProMetic Life-Sciences Inc. Basic Information List
    Table 62. ProMetic Life-Sciences Inc. Description and Business Overview
    Table 63. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of ProMetic Life-Sciences Inc. (2019-2024)
    Table 65. ProMetic Life-Sciences Inc. Recent Developments
    Table 66. BioLine Rx Ltd Basic Information List
    Table 67. BioLine Rx Ltd Description and Business Overview
    Table 68. BioLine Rx Ltd Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of BioLine Rx Ltd (2019-2024)
    Table 70. BioLine Rx Ltd Recent Developments
    Table 71. Genzyme Corporation Basic Information List
    Table 72. Genzyme Corporation Description and Business Overview
    Table 73. Genzyme Corporation Kidney (Renal) Fibrosis Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Kidney (Renal) Fibrosis Business of Genzyme Corporation (2019-2024)
    Table 75. Genzyme Corporation Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Kidney (Renal) Fibrosis Downstream Customers
    Table 79. Kidney (Renal) Fibrosis Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Kidney (Renal) Fibrosis Product Picture
    Figure 2. Global Kidney (Renal) Fibrosis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Kidney (Renal) Fibrosis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Kidney (Renal) Fibrosis Report Years Considered
    Figure 5. Global Kidney (Renal) Fibrosis Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Kidney (Renal) Fibrosis Revenue in 2023
    Figure 7. Kidney (Renal) Fibrosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Angiotensin Converting enzyme (ACE) Inhibitors Picture
    Figure 9. Pirfenidone Picture
    Figure 10. Renin Inhibitors Picture
    Figure 11. Angiotensin II Receptor Blockers (ARBs) Picture
    Figure 12. Vasopeptidase Inhibitors Picture
    Figure 13. Global Kidney (Renal) Fibrosis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Kidney (Renal) Fibrosis Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Research Center
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Clinic
    Figure 18. Global Kidney (Renal) Fibrosis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Kidney (Renal) Fibrosis Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Kidney (Renal) Fibrosis Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Kidney (Renal) Fibrosis Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Kidney (Renal) Fibrosis Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Kidney (Renal) Fibrosis Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Kidney (Renal) Fibrosis Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Kidney (Renal) Fibrosis Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Kidney (Renal) Fibrosis Sales Value (%), (2019-2030)
    Figure 31. United States Kidney (Renal) Fibrosis Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Kidney (Renal) Fibrosis Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Kidney (Renal) Fibrosis Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Kidney (Renal) Fibrosis Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Kidney (Renal) Fibrosis Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Kidney (Renal) Fibrosis Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Kidney (Renal) Fibrosis Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Kidney (Renal) Fibrosis Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Kidney (Renal) Fibrosis Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Kidney (Renal) Fibrosis Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Kidney (Renal) Fibrosis Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Kidney (Renal) Fibrosis Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Kidney (Renal) Fibrosis Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Kidney (Renal) Fibrosis Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Kidney (Renal) Fibrosis Sales Value by Application (%), 2023 VS 2030
    Figure 52. Kidney (Renal) Fibrosis Industrial Chain
    Figure 53. Kidney (Renal) Fibrosis Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Treatment Market Research Report 2025
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025
End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Medicine Market Insights Forecast to 2030
Global CKD and ESRD Treatment Market Research Report 2025
Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Renal Dialysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Retroperitoneal Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Disease Treatment Market Research Report 2024
C3 Glomerulopathy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Kidney Dialysis Machines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Membranous Nephropathy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025

RELATED REPORTS

Global Insulin Glargine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-2316
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Bilirubin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-35U2436
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Intracardiac Echocardiography Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7J13314
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global End Stage Renal Disease Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2F6212
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions
OSZAR »